• Je něco špatně v tomto záznamu ?

A critical review to identify data gaps and improve risk assessment of bisphenol A alternatives for human health

S. Mhaouty-Kodja, D. Zalko, S. Tait, E. Testai, C. Viguié, E. Corsini, N. Grova, FM. Buratti, NJ. Cabaton, L. Coppola, A. De la Vieja, M. Dusinska, N. El Yamani, V. Galbiati, P. Iglesias-Hernández, Y. Kohl, A. Maddalon, F. Marcon, L. Naulé, E....

. 2024 ; 54 (10) : 696-753. [pub] 20241022

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc25003591

Bisphenol A (BPA), a synthetic chemical widely used in the production of polycarbonate plastic and epoxy resins, has been associated with a variety of adverse effects in humans including metabolic, immunological, reproductive, and neurodevelopmental effects, raising concern about its health impact. In the EU, it has been classified as toxic to reproduction and as an endocrine disruptor and was thus included in the candidate list of substances of very high concern (SVHC). On this basis, its use has been banned or restricted in some products. As a consequence, industries turned to bisphenol alternatives, such as bisphenol S (BPS) and bisphenol F (BPF), which are now found in various consumer products, as well as in human matrices at a global scale. However, due to their toxicity, these two bisphenols are in the process of being regulated. Other BPA alternatives, whose potential toxicity remains largely unknown due to a knowledge gap, have also started to be used in manufacturing processes. The gradual restriction of the use of BPA underscores the importance of understanding the potential risks associated with its alternatives to avoid regrettable substitutions. This review aims to summarize the current knowledge on the potential hazards related to BPA alternatives prioritized by European Regulatory Agencies based on their regulatory relevance and selected to be studied under the European Partnership for the Assessment of Risks from Chemicals (PARC): BPE, BPAP, BPP, BPZ, BPS-MAE, and TCBPA. The focus is on data related to toxicokinetic, endocrine disruption, immunotoxicity, developmental neurotoxicity, and genotoxicity/carcinogenicity, which were considered the most relevant endpoints to assess the hazard related to those substances. The goal here is to identify the data gaps in BPA alternatives toxicology and hence formulate the future directions that will be taken in the frame of the PARC project, which seeks also to enhance chemical risk assessment methodologies using new approach methodologies (NAMs).

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003591
003      
CZ-PrNML
005      
20250206104432.0
007      
ta
008      
250121s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/10408444.2024.2388712 $2 doi
035    __
$a (PubMed)39436315
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Mhaouty-Kodja, Sakina $u CNRS UMR 8246, INSERM U1130, Neuroscience Paris Seine - Institut de Biologie Paris Seine, Sorbonne Université, Paris, France
245    12
$a A critical review to identify data gaps and improve risk assessment of bisphenol A alternatives for human health / $c S. Mhaouty-Kodja, D. Zalko, S. Tait, E. Testai, C. Viguié, E. Corsini, N. Grova, FM. Buratti, NJ. Cabaton, L. Coppola, A. De la Vieja, M. Dusinska, N. El Yamani, V. Galbiati, P. Iglesias-Hernández, Y. Kohl, A. Maddalon, F. Marcon, L. Naulé, E. Rundén-Pran, F. Salani, N. Santori, M. Torres-Ruiz, JD. Turner, O. Adamovsky, K. Aiello-Holden, H. Dirven, H. Louro, MJ. Silva
520    9_
$a Bisphenol A (BPA), a synthetic chemical widely used in the production of polycarbonate plastic and epoxy resins, has been associated with a variety of adverse effects in humans including metabolic, immunological, reproductive, and neurodevelopmental effects, raising concern about its health impact. In the EU, it has been classified as toxic to reproduction and as an endocrine disruptor and was thus included in the candidate list of substances of very high concern (SVHC). On this basis, its use has been banned or restricted in some products. As a consequence, industries turned to bisphenol alternatives, such as bisphenol S (BPS) and bisphenol F (BPF), which are now found in various consumer products, as well as in human matrices at a global scale. However, due to their toxicity, these two bisphenols are in the process of being regulated. Other BPA alternatives, whose potential toxicity remains largely unknown due to a knowledge gap, have also started to be used in manufacturing processes. The gradual restriction of the use of BPA underscores the importance of understanding the potential risks associated with its alternatives to avoid regrettable substitutions. This review aims to summarize the current knowledge on the potential hazards related to BPA alternatives prioritized by European Regulatory Agencies based on their regulatory relevance and selected to be studied under the European Partnership for the Assessment of Risks from Chemicals (PARC): BPE, BPAP, BPP, BPZ, BPS-MAE, and TCBPA. The focus is on data related to toxicokinetic, endocrine disruption, immunotoxicity, developmental neurotoxicity, and genotoxicity/carcinogenicity, which were considered the most relevant endpoints to assess the hazard related to those substances. The goal here is to identify the data gaps in BPA alternatives toxicology and hence formulate the future directions that will be taken in the frame of the PARC project, which seeks also to enhance chemical risk assessment methodologies using new approach methodologies (NAMs).
650    _2
$a zvířata $7 D000818
650    _2
$a lidé $7 D006801
650    12
$a benzhydrylové sloučeniny $x chemie $x toxicita $7 D001559
650    12
$a endokrinní disruptory $x chemie $x toxicita $7 D052244
650    _2
$a hodnocení rizik $x metody $7 D018570
650    _2
$a sulfony $x toxicita $7 D013450
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Zalko, Daniel $u INRAE, UMR1331 Toxalim (Research Center in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UT3, Toulouse, France
700    1_
$a Tait, Sabrina $u Center for Gender-Specific Medicine, Istituto Superiore di Sanità, Rome, Italy
700    1_
$a Testai, Emanuela $u Department of Environment and Health, Mechanisms, Biomarkers and Models Unit, Istituto Superiore di Sanità, Rome, Italy $1 https://orcid.org/0000000331135103
700    1_
$a Viguié, Catherine $u INRAE, UMR1331 Toxalim (Research Center in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UT3, Toulouse, France
700    1_
$a Corsini, Emanuela $u Department of Pharmacological and Biomolecular Sciences 'Rodolfo Paoletti', Università degli Studi di Milano - School of Pharmacy, Milan, Italy
700    1_
$a Grova, Nathalie $u Department of Infection and Immunity, Immune Endocrine Epigenetics Research Group, Luxembourg Institute of Health, Esch-Sur-Alzette, Luxembourg
700    1_
$a Buratti, Franca Maria $u Department of Environment and Health, Mechanisms, Biomarkers and Models Unit, Istituto Superiore di Sanità, Rome, Italy
700    1_
$a Cabaton, Nicolas J $u INRAE, UMR1331 Toxalim (Research Center in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UT3, Toulouse, France
700    1_
$a Coppola, Lucia $u Center for Gender-Specific Medicine, Istituto Superiore di Sanità, Rome, Italy
700    1_
$a De la Vieja, Antonio $u Endocrine Tumor Unit from Chronic Disease Program (UFIEC), Instituto de Salud Carlos III (ISCIII), Majadahonda, Madrid, Spain
700    1_
$a Dusinska, Maria $u Department for Environmental Chemistry, Health Effects Laboratory, NILU-Norwegian Institute for Air Research, Kjeller, Norway
700    1_
$a El Yamani, Naouale $u Department for Environmental Chemistry, Health Effects Laboratory, NILU-Norwegian Institute for Air Research, Kjeller, Norway
700    1_
$a Galbiati, Valentina $u Department of Pharmacological and Biomolecular Sciences 'Rodolfo Paoletti', Università degli Studi di Milano - School of Pharmacy, Milan, Italy
700    1_
$a Iglesias-Hernández, Patricia $u Endocrine Tumor Unit from Chronic Disease Program (UFIEC), Instituto de Salud Carlos III (ISCIII), Majadahonda, Madrid, Spain
700    1_
$a Kohl, Yvonne $u Fraunhofer Institute for Biomedical Engineering IBMT, Sulzbach, Germany
700    1_
$a Maddalon, Ambra $u Department of Pharmacological and Biomolecular Sciences 'Rodolfo Paoletti', Università degli Studi di Milano - School of Pharmacy, Milan, Italy
700    1_
$a Marcon, Francesca $u Department of Environment and Health, Mechanisms, Biomarkers and Models Unit, Istituto Superiore di Sanità, Rome, Italy
700    1_
$a Naulé, Lydie $u CNRS UMR 8246, INSERM U1130, Neuroscience Paris Seine - Institut de Biologie Paris Seine, Sorbonne Université, Paris, France
700    1_
$a Rundén-Pran, Elise $u Department for Environmental Chemistry, Health Effects Laboratory, NILU-Norwegian Institute for Air Research, Kjeller, Norway
700    1_
$a Salani, Francesca $u Department of Environment and Health, Mechanisms, Biomarkers and Models Unit, Istituto Superiore di Sanità, Rome, Italy
700    1_
$a Santori, Nicoletta $u Department of Environment and Health, Mechanisms, Biomarkers and Models Unit, Istituto Superiore di Sanità, Rome, Italy
700    1_
$a Torres-Ruiz, Mónica $u National Center for Environmental Health (CNSA), Instituto de Salud Carlos III (ISCIII), Majadahonda, Madrid, Spain
700    1_
$a Turner, Jonathan D $u Department of Infection and Immunity, Immune Endocrine Epigenetics Research Group, Luxembourg Institute of Health, Esch-Sur-Alzette, Luxembourg
700    1_
$a Adamovsky, Ondrej $u Faculty of Science, Masaryk University, RECETOX, Brno, Czech Republic
700    1_
$a Aiello-Holden, Kiara $u German Federal Institute for Risk Assessment (BfR), Berlin, Germany
700    1_
$a Dirven, Hubert $u Department of Chemical Toxicology - Division of Climate and the Environment, Norwegian Institute of Public Health, Oslo, Norway
700    1_
$a Louro, Henriqueta $u Department of Human Genetics, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal $u Centre for Toxicogenomics and Human Health, Nova Medical School, Universidade Nova de Lisboa, Lisbon, Portugal
700    1_
$a Silva, Maria João $u Department of Human Genetics, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal $u Centre for Toxicogenomics and Human Health, Nova Medical School, Universidade Nova de Lisboa, Lisbon, Portugal
773    0_
$w MED00011293 $t Critical reviews in toxicology $x 1547-6898 $g Roč. 54, č. 10 (2024), s. 696-753
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39436315 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104427 $b ABA008
999    __
$a ok $b bmc $g 2263377 $s 1239598
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 54 $c 10 $d 696-753 $e 20241022 $i 1547-6898 $m Critical reviews in toxicology $n Crit Rev Toxicol $x MED00011293
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Možnosti archivace